Trademarkia Logo

Australia

AU$
XPELCER
Cancelled: Cancelled at the request of IB

Last updated on 12 Feb 2025

Owner Info

Alexion Pharmaceuticals, Inc.

121 Seaport Boulevard

Boston MA 02210, UNITED STATES OF AMERICA

Serial Number

2186977 filed on 13 Apr 2021

Correspondent

Dennemeyer & Associates S.A.

55 rue des Bruyères,

L-1274 Howald,

LUXEMBOURG

XPELCER

Classification Information


Class [005]
Pharmaceutical preparations.

Mark Details


Serial Number

2186977

Registered On

13 Apr 2021

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

21 Oct 2020

Mark Type

US

Legal History


Show more

Status DateAction Taken
12th Feb 2025Status change to Voided
9th May 2024Amendment to International Registration Contact Requested
2th Sept 2021International Registration in Australia Protected correspondence sent
1st Sept 2021IP Right Registration Published
1st Sept 2021Status change to Registered/Protected
26th Jun 2021Application Accepted correspondence sent
25th Jun 2021IP Right has been Examined
25th Jun 2021IP Right Acceptance Published
25th Jun 2021Status change to Accepted
24th Jun 2021Examination expedited